CXCL10 and leishmaniasis: Since IP-10 identifies HIV/tuberculosis-infected patients, despite their low CD4 counts (Azzurri et al., 2005; Kassa et al., 2016), it might be used to monitor for relapses of leishmaniasis in HIV/Leishmania-infected patients.